SHANCHOL

Indications

• Prevention of influenza
• Prevention of human papillomavirus infection
• Prevention of certain bacterial infections

Dosage

Children: Refer to specific bivalent vaccine product information for paediatric dosing guidelines.

Adults: Refer to specific bivalent vaccine product information for dosing guidelines.

Mechanism of action

Bivalent vaccines work by introducing two distinct antigens into the body, which stimulates the immune system to recognize and respond to both antigens. This results in the production of antibodies specific to each antigen, leading to immunological memory that can provide protection against future infections with those pathogens.

Pharmacodynamics

The pharmacodynamics of bivalent vaccines involve the activation of both humoral and cellular immune responses. Upon administration, antigen-presenting cells capture the vaccine antigens, process them, and present them to T cells. This leads to the activation of T helper cells, which in turn stimulate B cells to produce antibodies. The antibodies neutralize the pathogens and mark them for destruction by other immune cells. The robust immune response aims to provide long-lasting protection against the targeted diseases.

Pharmacokinetics

The pharmacokinetics of bivalent vaccines primarily involve the absorption of antigens into the body, the distribution of these antigens to lymphoid tissues, and the subsequent immune response. Vaccines are typically administered intramuscularly or subcutaneously, allowing for rapid absorption into the bloodstream. The onset of immune response may vary, but typically, peak antibody levels can be observed within weeks to months post-vaccination. The duration of immunity also varies based on the specific vaccine and the antigens included.

Pregnancy

Bivalent vaccines have not shown teratogenic effects in animal studies, but data on human pregnancy is limited. Consult healthcare providers before administration.

Breast-feeding

Limited data is available on the effects of bivalent vaccines during breastfeeding. Generally considered safe, but consult healthcare providers for individual assessment.

Storage

Store at 2 to 8 degrees Celsius. Do not freeze. Protect from light.

Indications

• Cancer (e.g., leukemia, lymphoma)
• Autoimmune diseases (e.g., lupus, rheumatoid arthritis)
• Cardiovascular diseases (e.g., myocardial infarction)
• Neurological disorders (e.g., Parkinson's disease, multiple sclerosis)
• Orthopedic conditions (e.g., osteoarthritis)
• Genetic disorders (e.g., cystic fibrosis)

Dosage

Children: Dosage varies widely based on the cell type and condition being treated. Refer to specific treatment protocols and guidelines.

Adults: Dosage varies widely based on the cell type and condition being treated. Refer to specific treatment protocols and guidelines.

Mechanism of action

Cell therapies can function through several mechanisms, including differentiation into specific cell types, secretion of bioactive factors that promote tissue repair, and modulation of the immune response. For example, in the case of stem cells, they can migrate to sites of injury and contribute to tissue regeneration and repair.

Pharmacodynamics

The pharmacodynamics of cell therapy depend on the type of cells used and their intended purpose. For immune cell therapies, such as CAR T-cell therapy, the activated T-cells seek out and destroy cancer cells. In regenerative medicine, stem cells can differentiate into various cell types, potentially restoring normal function in damaged tissues. The therapeutic effects may also be mediated through paracrine signaling, where the cells release signaling molecules that enhance healing processes.

Pharmacokinetics

The pharmacokinetics of cell therapies include factors such as cell migration, engraftment, and survival within the host. After administration, cells may migrate to the target tissue, where they ideally engraft and proliferate. The lifespan of administered cells can vary significantly depending on the cell type and the patient's immune response. For example, some immune cells may have a short half-life, while stem cells may persist longer and contribute to ongoing tissue repair.

Pregnancy

There is limited data on the safety of this drug during pregnancy. It should be used only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Caution is advised when administering this drug to breastfeeding mothers, as it may pass into breast milk and affect the nursing infant.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Acute watery diarrhea caused by cholera
• Severe dehydration due to cholera
• Electrolyte imbalances resulting from cholera

Dosage

Children: Refer to guidelines for specific rehydration protocols and antibiotic choices based on local guidelines.

Adults: Refer to guidelines for specific rehydration protocols and antibiotic choices based on local guidelines.

Mechanism of action

The pathogenicity of Vibrio cholerae is largely due to the cholera toxin (CT), which is an AB toxin. The A subunit of the toxin enters intestinal epithelial cells and activates adenylate cyclase, leading to an increase in cyclic AMP (cAMP) levels. Elevated cAMP causes secretion of chloride ions into the intestinal lumen, accompanied by sodium and water, resulting in profuse watery diarrhea.

Pharmacodynamics

The primary pharmacodynamic effect in cholera treatment is the restoration of fluid and electrolyte balance through rehydration. In cases where antibiotics are used, they reduce the bacterial load and the production of cholera toxin, leading to a decrease in diarrhea and gastrointestinal symptoms. The choice of antibiotic can influence the speed of recovery and the reduction of stool output.

Pharmacokinetics

Cholera treatment focuses on fluid replacement rather than pharmacokinetics of a specific drug. Oral rehydration solutions (ORS) are designed to be absorbed efficiently in the intestines. If antibiotics are administered, pharmacokinetics will vary depending on the specific antibiotic used. Generally, the absorption of orally administered antibiotics can be affected by the state of hydration and intestinal motility in cholera patients.

Adverse effects

• Dehydration
• Electrolyte imbalance
• Hypotension
• Acute kidney injury
• Shock

Precautions

• Monitor hydration status
• Electrolyte replacement may be necessary
• Use with caution in patients with pre-existing renal issues

Pregnancy

Cholera is a severe diarrheal disease. Pregnant women are at increased risk for severe complications if infected. Vaccination may be considered based on risk of exposure.

Breast-feeding

Cholera vaccination is generally considered safe during breastfeeding, but consult health care provider for specific recommendations.

Storage

Store at room temperature, away from moisture and heat. Maintain proper sanitation and hygiene to prevent contamination.

Formulations

• Oral rehydration salts
• Cholera vaccine (inactivated)

Indications

• Influenza prevention
• Hepatitis A prevention
• Rabies prophylaxis
• Polio prevention
• Typhoid fever prevention

Dosage

Children: Refer to specific vaccine guidelines for paediatric dosing, as it varies depending on the vaccine type and indication.

Adults: Refer to specific vaccine guidelines for adult dosing, as it varies depending on the vaccine type and indication.

Mechanism of action

Killed vaccines work by presenting inactivated pathogens or their components (antigens) to the immune system. This exposure prompts the immune system to produce antibodies and memory cells, preparing the body to respond to future infections by the live version of the pathogen. The inactivation process ensures that the vaccine is safe and cannot cause disease.

Pharmacodynamics

The pharmacodynamics of killed vaccines involve the activation of the immune system, specifically the adaptive immune response. Upon administration, the immune system recognizes the inactivated antigens as foreign, leading to the activation of T-cells and B-cells. B-cells produce antibodies against the specific pathogen, which can remain in the body for a prolonged period, providing immunity against future infections. The response may vary based on the individual and the specific vaccine used.

Pharmacokinetics

Killed vaccines do not undergo metabolism in the traditional sense as they are not pharmacological agents that exert effects systemically. Instead, they are processed through the immune system. After administration, the inactivated pathogens are taken up by antigen-presenting cells, which process the antigens and present them to T-cells. The immune response can take days to weeks to develop fully. The duration of immunity may vary depending on the vaccine and the individual's immune response.

Pregnancy

Consult healthcare provider. Safety during pregnancy has not been established.

Breast-feeding

Consult healthcare provider. Safety during breastfeeding has not been established.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Prevention of infectious diseases such as measles, mumps, rubella, hepatitis B, influenza, and human papillomavirus (HPV)
• Travel vaccinations for diseases endemic to certain regions
• Vaccination for at-risk populations, such as those with compromised immune systems or specific occupational exposures

Dosage

Children: Dosage varies by vaccine type and age; refer to the BNF for Children for specific dosing information.

Adults: Dosage varies by vaccine type and indication; refer to specific guidelines for each vaccine.

Mechanism of action

Vaccines work by mimicking an infection. They introduce a harmless component of a pathogen (antigen) to the immune system, prompting the body to produce an immune response. This includes the generation of antibodies and memory cells that provide long-term immunity. Upon subsequent exposure to the actual pathogen, the immune system is primed to respond more rapidly and effectively.

Pharmacodynamics

The pharmacodynamics of vaccines involves the activation of both humoral and cellular immunity. Vaccines stimulate B cells to produce antibodies against the pathogen, while T cells are activated to destroy infected cells. This dual response helps to establish immunological memory, which enables a faster and more robust response upon re-exposure to the pathogen.

Pharmacokinetics

Vaccines are administered via various routes, including intramuscular, subcutaneous, and oral. After administration, the antigens are presented to antigen-presenting cells, which activate T cells and stimulate B cell proliferation and differentiation. The half-life of vaccine-induced immunity varies depending on the type of vaccine, with some providing lifelong immunity and others requiring booster doses to maintain protection.

Contra-indications

• Severe allergic reaction (anaphylaxis) to a component of the vaccine
• Severe immunocompromised state for live attenuated vaccines

Adverse effects

• Local reactions at the injection site (pain, redness, swelling)
• Fever
• Fatigue
• Headache
• Muscle pain
• Joint pain
• Nausea

Interactions

• Immunosuppressive medications may reduce vaccine efficacy
• Concurrent administration of some vaccines may require spacing to optimize immune response

Precautions

• History of allergic reactions to vaccines or vaccine components
• Pregnancy (specific vaccines may be contraindicated)
• Moderate to severe acute illness with or without fever

Pregnancy

Consult healthcare provider. Some vaccines are contraindicated during pregnancy, while others are recommended.

Breast-feeding

Generally considered safe, but consult healthcare provider regarding specific vaccines.

Storage

Store in a refrigerator at 2-8°C. Do not freeze. Protect from light.

Formulations

• Liquid suspension for injection
• Lyophilized powder for reconstitution

Dosage

Children: Paediatric dosing for whole products also varies and should be determined by specific products and clinical considerations; consult relevant paediatric pharmacology references for precise information.

Adults: Dosage for whole products is highly variable and should be guided by specific formulations and the clinical context; refer to the appropriate pharmacological references for guidance.

Mechanism of action

The mechanism of action for whole substances varies widely based on the specific plant or compound. Generally, phytochemicals in whole herbs may interact with various biological pathways, such as modulating the immune response, influencing neurotransmitter systems, or exhibiting antioxidant properties. For example, compounds like flavonoids and alkaloids can affect cellular signaling pathways and may impact inflammation, metabolism, or cell proliferation.

Pharmacodynamics

Pharmacodynamics of whole substances also varies greatly. The active compounds may exhibit dose-dependent effects, where low concentrations could stimulate certain biological pathways while higher concentrations may have inhibitory effects. The synergy among multiple components in whole products can enhance efficacy and reduce toxicity compared to isolated compounds, contributing to their therapeutic profiles.

Pharmacokinetics

The pharmacokinetics of whole herbal preparations depend on the specific constituents present. These factors include absorption rates, distribution throughout the body, metabolism (often involving hepatic pathways), and excretion (typically via renal pathways). The complex mixture of compounds can affect bioavailability and the overall pharmacokinetic profile, with some components exhibiting prolonged half-lives or effects due to their interaction with metabolic enzymes.

Pregnancy

The safety of this drug during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known if this drug is excreted in human milk. Caution is advised when administering to nursing mothers.

Storage

Store in a cool, dry place, away from direct light. Keep out of reach of children.